{"id":385995,"date":"2022-03-30T00:00:00","date_gmt":"2022-03-30T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47031075-medtech-electrophysiology-mapping-and-ablation-devices-market-insights-asia-pacific-supplemental\/"},"modified":"2026-04-21T11:04:33","modified_gmt":"2026-04-21T11:04:33","slug":"47031075-medtech-electrophysiology-mapping-and-ablation-devices-market-insights-asia-pacific-supplemental","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47031075-medtech-electrophysiology-mapping-and-ablation-devices-market-insights-asia-pacific-supplemental\/","title":{"rendered":"Electrophysiology Mapping and Ablation Devices | Market Insights | Asia Pacific (Supplemental) | 2022"},"content":{"rendered":"<p>Growing\u00a0AF\u00a0treatment volumes, driven by an expanding patient pool, rising awareness of ablation procedures, and improving access to health care, will fuel strong growth in the Asia Pacific\u00a0EP\u00a0mapping and ablation device market through 2030. However, the\u00a0COVID-19\u00a0global pandemic will have an impact on the Asia Pacific\u00a0EP\u00a0mapping and ablation device market, resulting in lost procedure volumes in the short term followed by a period of recovery. This is expected to reduce the growth of the\u00a0EP\u00a0mapping and ablation device market.<\/p>\n<p>This Medtech 360 Report provides high-level market metrics for\u00a0EP\u00a0mapping and ablation devices in the Asia Pacific region, including country-level data for major countries and aggregate data for the rest of Asia Pacific, across a 11-year period.<\/p>\n","protected":false},"template":"","class_list":["post-385995","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiovascular","medtech-therapy-area-electrophysiology-mapping-and-ablation-devices","medtech-geography-asia-pacific","medtech-date-967"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385995","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385995\/revisions"}],"predecessor-version":[{"id":387504,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385995\/revisions\/387504"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=385995"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}